Dark Urine

Table of Contents

1. Overview
2. What Determines Urine Color
3. Common Causes
4. Evaluation
5. Management
6. Signs That Point to a Serious Cause
7. Connections
8. Key Research Papers
9. Featured Videos

Overview

Dark urine describes urine that appears tea-, cola-, brown-, or amber-colored rather than the normal pale to medium yellow. It is a non-specific sign that can reflect simple dehydration, medications and foods, blood in the urine, muscle breakdown, or — most importantly — liver and biliary disease. When dark urine accompanies jaundice, pale stools, fatigue, or right upper quadrant pain, it strongly suggests a hepatobiliary problem and warrants prompt evaluation.

Historical Background

Examination of urine — uroscopy — has been a cornerstone of medicine since antiquity, with detailed color charts in use throughout the medieval period. Modern dipstick urinalysis emerged in the 1950s, allowing rapid bedside detection of bilirubin, urobilinogen, blood, protein, and other markers. The recognition that conjugated bilirubinuria precedes clinical jaundice in liver disease has made urine testing an early warning system for hepatobiliary illness.

What Determines Urine Color

Normal urine color comes from urochrome (urobilin), a yellow pigment derived from the breakdown of hemoglobin and ultimately bilirubin. The deeper the color, the more concentrated the urine. Several other substances can change urine color dramatically:

• Conjugated bilirubin — water-soluble, spills into urine when liver or biliary disease is present, producing tea or cola color.
• Hemoglobin or red blood cells — pink, red, or smoky brown urine from hematuria or hemolysis.
• Myoglobin — released during muscle breakdown (rhabdomyolysis), produces tea-colored urine that tests positive for "blood" but contains no red cells.
• Porphyrins — purple-red urine that may darken on standing in porphyria.

Urine color is a rough guide to hydration. In two laboratory studies and one field study (Armstrong, 1994), a numbered urine-color scale tracked closely with how concentrated the urine was (its specific gravity and osmolality). The authors concluded that color works for sport, work and field settings where a close estimate is enough, but is less precise than a laboratory measurement.

Common Causes

• Dehydration — the most common cause; concentrated urine appears darker yellow or amber.
• Liver and biliary disease — viral hepatitis, cirrhosis, biliary obstruction (gallstones, tumors). Conjugated bilirubin appears in urine before clinical jaundice is visible.
• Hemolysis — sickle cell crisis, glucose-6-phosphate dehydrogenase (G6PD) deficiency, autoimmune hemolytic anemia, transfusion reactions, severe malaria (blackwater fever). In people with G6PD deficiency, eating fava (broad) beans can set off sudden red-cell breakdown called favism; a 2023 review of case reports describes jaundice, discolored urine, a fast heartbeat, pallor and abdominal pain at all ages, kidney failure in adults, and the most severe cases in infants and pregnant women, with hospital care and blood transfusion often needed.
• Hematuria — kidney stones, urinary tract infection, glomerulonephritis, bladder or kidney cancer, trauma.
• Rhabdomyolysis — crush injury, prolonged immobilization, statin myopathy, intense exercise.
• Foods — beets, blackberries, rhubarb, food coloring (fava beans are a different matter: see favism under Hemolysis).
• Medications — rifampin, metronidazole, nitrofurantoin, phenazopyridine (orange-red), levodopa, methyldopa, senna, chloroquine.
• Porphyria — rare inherited disorders of heme metabolism.

Evaluation

• Urinalysis with microscopy — distinguishes hematuria (red cells present) from hemoglobinuria/myoglobinuria (positive blood, no cells) and detects bilirubin and urobilinogen.
• Liver function panel — bilirubin (total and direct), alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase, gamma-glutamyl transferase (GGT).
• Complete blood count and reticulocyte count — for hemolysis.
• Creatine kinase — markedly elevated in rhabdomyolysis.
• Urine culture — if infection is suspected.
• Imaging — renal ultrasound or computed tomography (CT) for stones, masses, or obstructive uropathy; right upper quadrant ultrasound for biliary disease.

Management

Management depends entirely on the underlying cause. Mild dehydration resolves with fluids. Hepatitis-related dark urine improves as liver inflammation subsides. Biliary obstruction may need endoscopic stone removal or stenting. Rhabdomyolysis requires aggressive intravenous hydration to protect the kidneys. Drug-related discoloration resolves when the medication is stopped. Phenazopyridine and rifampin discoloration is harmless and expected.

Signs That Point to a Serious Cause

• Dark urine accompanied by yellow skin or eyes (jaundice).
• Visible blood, clots, or pink/red discoloration not explained by foods.
• Associated flank or abdominal pain, fever, or chills.
• After significant muscle injury, prolonged immobilization, or new statin therapy with muscle aches.
• Persistent dark urine despite adequate hydration.

Connections

• All Symptoms
• Jaundice
• Hepatitis
• Liver Disease
• Kidney Stones
• Sickle Cell Disease
• Pale Stool
• Urinary Tract Infections
• Cirrhosis
• Anemia
• Urinalysis
• Kidney Disease
• Fatigue
• Abdominal Pain
• Non-Alcoholic Fatty Liver Disease
• Malaria
• Hepatitis B
• Hepatitis C
• Loss Of Appetite
• Kidney Cancer
• Frequent Urination

Key Research Papers

1. Cohen RA, Brown RS. Microscopic hematuria. New England Journal of Medicine. 2003;348(23):2330-2338. — doi:10.1056/nejmcp012694
2. Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. New England Journal of Medicine. 2009;361(1):62-72. — doi:10.1056/NEJMra0801327
3. Aycock RD, Kass DA. Abnormal urine color. Southern Medical Journal. 2012;105(1):43-47. — doi:10.1097/smj.0b013e31823c413e
4. Kelly JD, Fawcett DP, Goldberg LC. Assessment and management of non-visible haematuria in primary care. BMJ. 2009;338:a3021. — doi:10.1136/bmj.a3021
5. Anderson KE, Bloomer JR, Bonkovsky HL, et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Annals of Internal Medicine. 2005;142(6):439-450. — doi:10.7326/0003-4819-142-6-200503150-00010
6. Simerville JA, Maxted WC, Pahira JJ. Urinalysis: a comprehensive review. American Family Physician. 2005;71(6):1153-1162. — PubMed PMID: 15791892
7. Tracz MJ, Alam J, Nath KA. Physiology and pathophysiology of heme: implications for kidney disease. Journal of the American Society of Nephrology. 2007;18(2):414-420. — doi:10.1681/asn.2006080894
8. Armstrong LE, Maresh CM, Castellani JW, Bergeron MF, Kenefick RW, LaGasse KE, Riebe D. Urinary indices of hydration status. International Journal of Sport Nutrition. 1994;4(3):265-279. — PubMed PMID: 7987361
9. Beretta A, Manuelli M, Cena H. Favism: clinical features at different ages. Nutrients. 2023;15(2):343. — PubMed PMID: 36678214

Back to Table of Contents

Featured Videos